This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

CVS/pharmacy's Project Health Targets Chronic Disease Through Free Health Screenings

Stocks in this article: CVS

WOONSOCKET, R.I., March 4, 2013 /PRNewswire/ -- CVS/pharmacy announced today the kickoff of its annual Project Health wellness campaign. In 2013, Project Health, known as Proyecto Salud in Spanish, will deliver more than $15 million worth of free health screenings to multicultural communities across the United States.

(Logo: http://photos.prnewswire.com/prnh/20120207/NE48106LOGO-a )

More than 750 Project Health events will be held at select CVS/pharmacy retail locations in 10 cities across the U.S., including Atlanta, Chicago, Dallas-Fort Worth, Detroit, Houston, Los Angeles, Miami, New York City, Philadelphia and Washington, DC. Events will also be held at select CVS/pharmacy stores in Puerto Rico.

Project Health will offer an array of free comprehensive health risk assessments including Body Mass Index (BMI), blood pressure, cholesterol, glucose screenings and smoking cessation counseling. Additional screenings that will be offered include Dental Care in October and Bone Density in May and November.  Information and education will also be offered each month based on recognized health awareness themes, such as nutrition assessment, lifestyle stress tests and breast cancer education. Additionally, children seven years of age and older may participate in this year's screenings with parental consent.

"Far too many of the multicultural populations we serve have difficulty accessing preventive care," said Troyen A. Brennan, M.D., M.P.H., Executive Vice President and Chief Medical Officer, CVS Caremark. "Project Health makes it easier for our customers to make their health a priority, offering them health risk assessments free of charge right in their neighborhoods. This program allows us to better reach customers who come from a wide array of ethnic and cultural backgrounds, ensuring that we are able to help all people on their path to better health."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs